Virtual Reality With Mirror Therapy on Upper Limb Function

December 6, 2024 updated by: Khalid Esmail Mohamed Mohamed, Kafrelsheikh University

Effect Of Virtual Reality With Mirror Therapy on Upper Limb Functions in Children With Hemiplegic Cerebral Palsy

The goal of this clinical trial is to address the effect of (Virtual Reality) and (Mirror Therapy) together on upper limb function in hemiplegic Cerebral Palsy children , male or female ranged between 3 to 10 years of age

. The main question of the study is Are there any significant differences between the effects of virtual reality , mirror therapy and the combined effect of both techniques and on upper limb function in hemiplegic CP children?

Participants will be subdevided into three groups A , B ,C Group (A): will receive VR in addition to designed physical therapy program Group (B): will receive MT in addition to designed physical therapy program Group (C): will receive the compound effect of both techniques in addition to designed physical therapy program

Study Overview

Detailed Description

The goal of this clinical trial is to address the effect of (Virtual Reality) and (Mirror Therapy) together on upper limb function in hemiplegic Cerebral Palsy children , male or female ranged between 3 to 10 years of age

. The main question of the study is Are there any significant differences between the effects of virtual reality (VR), mirror therapy (MR) and the combined effect of both techniques (VR) and (MR) on upper limb function in hemiplegic CP children?

Participants will be subdevided into three groups A , B ,C Group (A): will receive VR in addition to designed physical therapy program Group (B): will receive MT in addition to designed physical therapy program Group (C): will receive the compound effect of both techniques in addition to designed physical therapy program

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Kafr Ash Shaykh, Egypt
        • faculty of physical therapy Kafrelshiekh university
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Children will be included in the study if they fulfil the following criteria:

    1. A medical diagnosis of spastic hemiplegic CP made by pediatric neurologists.
    2. Children with spasticity grades ranged from 1 to 1+ according to MAS.
    3. Their age range from 4 to 10 years.
    4. Children level 1 and level 2 in gross motor functional classification (GMFC 1&2)

Exclusion Criteria:

  • Children will be excluded from the study if:

    1. They had a permanent deformity (bony or soft tissue contractures).
    2. Children having visual or auditory defects.
    3. Children who can not understand verbal commands
    4. Children who had Botox application to the upper extremity in the past 6 months or had undergone a previous surgical intervention to wrist and hand.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group (A) virtual reality group
this group will receive virtual reality intervention plus designed physical therapy program

In Xbox, we will choose suitable games that aim to improve upper limb function like boxing, Darts, tennis, goalkeeping, basketball, disc throwing, balling, and volleyball.

The Kinect sensor has the advantage of auto adjustment of its camera according to the child's position and height that's to say the child can perform the game in sitting or standing according to their abilities.

They will receive 30 minutes of VR intervention in addition to the time required for the designed physical therapy program.

Active Comparator: Group (B) mirror therapy group
this group will receive mirror therapy intervention plus designed physical therapy program
Mirror Therapy A mirror of 30 × 20 inches was used for the MT, which was large enough to cover the entire affected limb while still allowing the reflection of the non-affected limb to be seen. The child was seated in a chair with the forearms resting on the table. In the mid-sagittal plane, the mirror box was positioned at an angle of 70° to 80° to the trunk. The affected limb was placed behind the mirror. The child was asked to perform the exercises bilaterally and symmetrically as much as possible. Even if the affected side did not move easily or fully, the child was advised to synchronize the motions with both hands and arms. The researcher constantly reminded the child to concentrate on the movement of the non-affected limb in front of the mirror, which helped to increase the mirror illusion
Active Comparator: Group (C) the compound effect of virtual reality and mirror therapy group
this group will receive virtual reality intervention , mirror therapy intervention plus designed physical threrapy program
group C will receive combined effect of both techniques (virtual reality and mirror therapy)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in upper limb functions
Time Frame: after 12 weeks of intervention
using quality of upper extremity skills test (Quest)
after 12 weeks of intervention
changes in power grip strength
Time Frame: after 12 weeks of intervention
using sphygmomanometer
after 12 weeks of intervention
changes in range of motion (ROM)
Time Frame: after 12 weeks of intervention
using kinovea software
after 12 weeks of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in activity of daily living (ADL)
Time Frame: after 12 weeks of intervention
using functional independence measure for children (WeeFIM):
after 12 weeks of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Mohamed B Ibrahim, Ass.Prof., head of pediatric department in faculty of physical therapy Kafrelshiekh university
  • Study Director: Osama A El-Agamy, Professor, Professor and head of department of pediatric department Faculty of medicine Kafrelshiekh university
  • Study Director: Sara Y Abdel Elglil, Lecturer, Lecturer in pediatric department in faculty of physical therapy Kafrelshiekh University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 10, 2024

Primary Completion (Estimated)

March 10, 2025

Study Completion (Estimated)

March 15, 2025

Study Registration Dates

First Submitted

December 6, 2024

First Submitted That Met QC Criteria

December 6, 2024

First Posted (Estimated)

December 11, 2024

Study Record Updates

Last Update Posted (Estimated)

December 11, 2024

Last Update Submitted That Met QC Criteria

December 6, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiplegic Cerebral Palsy

Clinical Trials on virtual reality

Subscribe